BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24399825)

  • 1. Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
    Cho JY; Hong KS; Kim HJ; Kim SH; Min JH; Kim NH; Ahn SW; Park MS; An JY; Kim BJ; Kim W
    Mult Scler; 2014 Aug; 20(9):1217-23. PubMed ID: 24399825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale.
    Hong KS; Saver JL
    Stroke; 2009 Dec; 40(12):3828-33. PubMed ID: 19797698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale.
    Ravnborg M; Blinkenberg M; Sellebjerg F; Ballegaard M; Larsen SH; Sørensen PS
    Mult Scler; 2005 Feb; 11(1):81-4. PubMed ID: 15732271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.
    Hobart J; Kalkers N; Barkhof F; Uitdehaag B; Polman C; Thompson A
    Mult Scler; 2004 Feb; 10(1):41-6. PubMed ID: 14760951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
    Bove R; Bevan C; Crabtree E; Zhao C; Gomez R; Garcha P; Morrissey J; Dierkhising J; Green AJ; Hauser SL; Cree BA; Wallin MT; Gelfand JM
    Mult Scler; 2019 Oct; 25(11):1526-1534. PubMed ID: 30141729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MS Impairment Scale: a pragmatic approach to the assessment of impairment in patients with multiple sclerosis.
    Ravnborg M; Grønbech-Jensen M; Jønsson A
    Mult Scler; 1997 Feb; 3(1):31-42. PubMed ID: 9160344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis.
    Solà-Valls N; Vicente-Pascual M; Blanco Y; Solana E; Llufriu S; Martínez-Heras E; Martínez-Lapiscina EH; Sepúlveda M; Pulido-Valdeolivas I; Zubizarreta I; Saiz A
    Mult Scler Relat Disord; 2019 Jan; 27():333-339. PubMed ID: 30472411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS-CANE: a computer-aided instrument for neurological evaluation of patients with multiple sclerosis: enhanced reliability of expanded disability status scale (EDSS) assessment.
    Cohen YC; Hassin-Baer S; Olmer L; Barishev R; Goldhammer Y; Freedman L; Mozes B
    Mult Scler; 2000 Oct; 6(5):355-61. PubMed ID: 11064447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composite end points to assess delay of disability progression by MS treatments.
    Zhang J; Waubant E; Cutter G; Wolinsky J; Leppert D
    Mult Scler; 2014 Oct; 20(11):1494-501. PubMed ID: 24675040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessing incapacity at early stages of Multiple sclerosis using the EDSS].
    Brochet B
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S173-9. PubMed ID: 19361684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vibration quantitation scale (VQS): a simple, reproducible bedside measure of sensory function in multiple sclerosis.
    Carter J; Wasser T; Statler S; Rae-Grant AD
    Can J Neurol Sci; 2004 Nov; 31(4):490-3. PubMed ID: 15595253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychometric properties of clinical rating scales used in multiple sclerosis.
    Sharrack B; Hughes RA; Soudain S; Dunn G
    Brain; 1999 Jan; 122 ( Pt 1)():141-59. PubMed ID: 10050902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of Patient-Reported Expanded Disability Status Scale tools.
    Collins CD; Ivry B; Bowen JD; Cheng EM; Dobson R; Goodin DS; Lechner-Scott J; Kappos L; Galea I
    Mult Scler; 2016 Sep; 22(10):1349-58. PubMed ID: 26564998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
    Hughes S; Spelman T; Trojano M; Lugaresi A; Izquierdo G; Grand'maison F; Duquette P; Girard M; Grammond P; Oreja-Guevara C; Hupperts R; Boz C; Bergamaschi R; Giuliani G; Rio ME; Lechner-Scott J; van Pesch V; Iuliano G; Fiol M; Verheul F; Barnett M; Slee M; Herbert J; Kister I; Vella N; Moore F; Petkovska-Boskova T; Shaygannejad V; Jokubaitis V; McDonnell G; Hawkins S; Kee F; Gray O; Butzkueven H;
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):305-10. PubMed ID: 22205675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.